A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Clinical trial NCT07351058 · RECRUITING
Trial details
- NCT number
- NCT07351058
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-23
- Primary completion
- 2028-08-07
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.